$0.6707
0.001000.15%
In chiusura: -
$0.7000
0.034.37%
After hour: Oct 3, 7:58 PM EDT
Tieni traccia delle ultime attività di insider trading Iterum Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Iterum Therapeutics.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Aug 12, 2025 | — | 15.00K | $0.72 | $10.85K | BUY | 6.82% | 235.00K | Aug 08 | ||
Dec 27, 2023 | DIRECTOR | 25.00K | $1.40 | $35.00K | BUY | 28.17% | 113.75K | Dec 22 | ||
Dec 19, 2023 | DIRECTOR | 10.00K | $1.84 | $18.44K | BUY | 12.70% | 88.75K | Dec 18 | ||
Nov 27, 2023 | DIRECTOR | 20.00K | $2.03 | $40.69K | BUY | 34.04% | 78.75K | Nov 22 | ||
Nov 20, 2023 | CHIEF EXECUTIVE OFFICER | 10.00K | $1.59 | $15.86K | BUY | 22.50% | 54.45K | Nov 20 | ||
Dec 05, 2022 | CHIEF MEDICAL OFFICER | 4.97K | $1.32 | -$4.44K | GRANT | ∞ | 4.97K | Dec 01 - Dec 02 | ||
Sep 20, 2022 | DIRECTOR | -37.25K | $1.82 | -$67.93K | SELL | -98.91% | 410.00 | Sep 16 - Sep 20 | ||
Sep 15, 2022 | DIRECTOR | -45.00K | $2.09 | -$93.85K | SELL | -54.44% | 37.66K | Sep 13 - Sep 15 | ||
Sep 12, 2022 | DIRECTOR | -33.30K | $2.31 | -$76.80K | SELL | -28.72% | 82.66K | Sep 08 - Sep 12 | ||
Sep 09, 2022 | DIRECTOR | 10.00K | $2.22 | $22.20K | BUY | 39.10% | 35.58K | Sep 07 | ||
Mar 15, 2022 | CHIEF FINANCIAL OFFICER | 52.87K | $0.38 | -$17.91K | GRANT | 184.65% | 81.50K | Mar 11 - Mar 14 | ||
Feb 12, 2021 | 10% OWNER | 0.00 | $2.43 | -$50.01M | SELL-OPTIONS | 0.00% | 0.00 | Feb 11 - Feb 12 | ||
Jan 27, 2021 | PRESIDENT & CEO | 82.06K | $1.73 | -$147.82K | GRANT | 34.20% | 322.01K | Jan 25 - Jan 26 | ||
Jan 27, 2021 | DIRECTOR | 46.86K | $1.73 | -$57.34K | GRANT | 22.37% | 256.36K | Jan 25 - Jan 26 | ||
Jan 27, 2021 | CHIEF FINANCIAL OFFICER | 28.63K | $1.73 | -$58.59K | GRANT | ∞ | 28.63K | Jan 25 - Jan 26 | ||
Oct 28, 2020 | — | 61.54K | $0.00 | $0.00 | PURCHASE | 41.59% | 209.50K | Oct 27 |
Sfoglia insider trading su tutte le azioni.